Theriva Biologics, Inc. TOVX
0.19 USD +0.01 (+4.40%)
At closeNov 4, 2026, 7:55 PM EST
0.18 -0.01 -5.16%
After hours · Nov 4, 7:55 PM ET
0.1764 Day range 0.1992
0.14 52-week range 0.49
- YTD
- -9.52%
- 1 year
- -36.67%
Analyst view
Price target (mean) 90.50 +47531.6% upside
Now 0.19
- Target (low)
- 6.00
- Target (mean)
- 90.50
- Target (high)
- 175.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy1
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -5.50 | -5.50 – -5.50 | -8.25 | +33.3% | 0 | 0.0% | 1 |
| Current year | -23.75 | -23.75 – -23.75 | -28.50 | +16.7% | 0 | 0.0% | 1 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 13, 2024 | Maxim Group | Maintained | Buy | Buy |
